FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer.
Dasari A, Sobrero A, Yao J, Yoshino T, Schelman W, Yang Z, Chien C, Kania M, Tabernero J, Eng C.
Future Oncol. 2021 Aug;17(24):3151-3162. doi: 10.2217/fon-2021-0202. Epub 2021 May 17.
PMID:33993740
CD64++ T cells.
Zhou T, Hou X, Yan J, Li L, Xie Y, Bai W, Jiang W, Zou Y, Li X, Liu Z, Zhang Z, Xu B, Mao G, Wang Y, Gao S, Wang X, Zhao T, Wang H, Sun H, Zhang X, Yu J, Huang C, Liu J, Hao J.
Gut. 2024 Nov 11;73(12):1984-1998. doi: 10.1136/gutjnl-2024-332371.
PMID:39187291
Estimating the potential risk of transmission of arboviruses in the Americas and Europe: a modelling study.
Zardini A, Menegale F, Gobbi A, Manica M, Guzzetta G, d'Andrea V, Marziano V, Trentini F, Montarsi F, Caputo B, Solimini A, Marques-Toledo C, Wilke ABB, Rosà R, Marini G, Arnoldi D, Pastore Y Piontti A, Pugliese A, Capelli G, Della Torre A, Teixeira MM, Beier JC, Rizzoli A, Vespignani A, Ajelli M, Merler S, Poletti P.